Ratings K+S AG

Equities

SDF

DE000KSAG888

Market Closed - Xetra Other stock markets 11:35:24 2024-05-31 am EDT			5-day change	1st Jan Change
13.5 ^EUR	-1.10%		+0.04%	-5.66%

May. 31	K+S : Warburg Research sticks Neutral	ZD
May. 22	K+S receives 600,000 euros in Zielitz and Bernburg	DP

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

The stock, which is currently worth 2024 to 0.64 times its sales, is clearly overvalued in comparison with peers.
The company appears to be poorly valued given its net asset value.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
The company sustains low margins.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 43.84 times its estimated earnings per share for the ongoing year.
The company is not the most generous with respect to shareholders' compensation.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Agricultural Chemicals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
K+S AG	-5.66%	2.62B		B
CORTEVA, INC.	+16.74%	38.99B		C
PHOSAGRO	-.--%	11.36B	-	B+
FMC CORPORATION	-3.33%	7.61B		A
PI INDUSTRIES LIMITED	+1.10%	6.45B		B-
ICL GROUP LTD	-4.79%	6.01B		B+
OCI N.V.	-4.50%	5.73B		B
YUNNAN YUNTIANHUA CO., LTD.	+32.88%	5.25B		B-
THE FERTILISERS AND CHEMICALS TRAVANCORE LIMITED	-16.30%	5.23B	-	C-
UPL LIMITED	-13.40%	4.58B		C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes